×
Alcon Long Term Debt 2019-2025 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon long term debt for the quarter ending March 31, 2025 was
$4.597B
, a
0.97% increase
year-over-year.
Alcon long term debt for 2024 was
$4.538B
, a
2.95% decline
from 2023.
Alcon long term debt for 2023 was
$4.676B
, a
2.97% increase
from 2022.
Alcon long term debt for 2022 was
$4.541B
, a
14.5% increase
from 2021.
View More
Alcon Long Term Debt 2019-2025 | ALC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Alcon long term debt for 2024 was
$4.538B
, a
2.95% decline
from 2023.
Alcon long term debt for 2023 was
$4.676B
, a
2.97% increase
from 2022.
Alcon long term debt for 2022 was
$4.541B
, a
14.5% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$171.9B
Thermo Fisher Scientific (TMO)
$161.4B
Edwards Lifesciences (EW)
$42B
IDEXX Laboratories (IDXX)
$33.3B
DexCom (DXCM)
$26.9B
IQVIA Holdings (IQV)
$25.4B
STERIS (STE)
$21.8B
Mettler-Toledo (MTD)
$20.9B
Waters (WAT)
$19.1B
SONOVA HOLDING (SONVY)
$17.3B
Fresenius Medical Care AG KGaA (FMS)
$13.9B
Hologic (HOLX)
$12.9B
Sysmex ADR (SSMXY)
$11.8B
Penumbra (PEN)
$10.7B
Globus Medical (GMED)
$9.8B
Masimo (MASI)
$8.2B
Teleflex (TFX)
$6B
Glaukos (GKOS)
$5.2B
Integer Holdings (ITGR)
$4.1B
TransMedics (TMDX)
$3B
PROCEPT BioRobotics (PRCT)
$2.9B
Veracyte (VCYT)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
LivaNova (LIVN)
$1.9B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.5B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.2B
Tandem Diabetes Care (TNDM)
$1.1B
Paragon 28 (FNA)
$1.1B